Relationship between sleep disturbances and psychoactive substance use disorders (alcohol and opioids): clinical and neurobiological aspects
Neurology Bulletin · 30.01.2026 · LVIII (1) · 58-70
DOI: 10.17816/nb688104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurology Bulletin, online erschienen am 30.01.2026. Verfasst von Valentin Yu. Skryabin und 2 weiteren Autor:innen. Die Arbeit nennt 80 Literaturangaben.
Abstract (Originalsprache)
This review provides a detailed analysis of the complex bidirectional relationship between sleep disturbances and substance use disorders, with a focus on alcohol and opioids. The available data on the neurobiological mechanisms underlying sleep dysfunction during intoxication, withdrawal, chronic use, and remission are structured (including the effects on GABAergic, adenosine, and opioid systems, as well as melanin-concentrating hormone). Characteristic changes in sleep architecture are reviewed, including suppression of slow-wave sleep and rapid eye movement sleep, development of insomnia, sleep-disordered breathing (obstructive and central sleep apnea, especially in the context of opioid use), and abnormalities of sleep microstructure (such as reduced evoked K-complexes in alcohol-related disorders). Particular attention is paid to clinical and epidemiological aspects emphasizing the role of sleep disturbances as a risk factor for the development of dependence syndrome (including self-medication of insomnia), difficulty achieving remission, and increased risk of relapse. Prospective studies demonstrate that poor sleep quality, reduced slow-wave sleep duration, and circadian rhythm disruption are independent predictors of relapse. Russian data confirm the high prevalence of sleep disturbances, reaching up to 70% at hospital admission. Current approaches to diagnosis (screening questionnaires; polysomnography) and comprehensive correction of sleep disorders in this subset of patients are discussed. Priority is given to cognitive behavioral therapy for insomnia and pharmacological strategies with low addictive potential (melatonin, trazodone, gabapentin, and orexin receptor antagonists). The need for further research into neurobiological mechanisms, age-related features, and the effectiveness of interventions (including neuromodulation and ampakines), aimed at normalizing sleep to improve treatment outcomes in psychoactive substance use disorders is emphasized.
Zitieren
APA
Skryabin, V. Y., Sokolova, S. I., & Masyakin, A. V. (2026). Relationship between sleep disturbances and psychoactive substance use disorders (alcohol and opioids): clinical and neurobiological aspects. Neurology Bulletin, LVIII(1), 58-70. https://doi.org/10.17816/nb688104
Vancouver
Skryabin VY, Sokolova SI, Masyakin AV. Relationship between sleep disturbances and psychoactive substance use disorders (alcohol and opioids): clinical and neurobiological aspects. Neurology Bulletin. 2026;LVIII(1):58-70. doi:10.17816/nb688104
BibTeX
@article{Skryabin2026,
author = {Skryabin, Valentin Yu. and Sokolova, Svetlana I. and Masyakin, Anton V.},
title = {Relationship between sleep disturbances and psychoactive substance use disorders (alcohol and opioids): clinical and neurobiological aspects},
journal = {Neurology Bulletin},
year = {2026},
volume = {LVIII},
number = {1},
pages = {58--70},
doi = {10.17816/nb688104}
}
EUVIMED